A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.
- Zhang, Alison (Primary Chief Investigator)
- Chapman, Nicola, (Chief Investigator)
- Butala, Radhika, (Chief Investigator)
Project: Other